Clinical Trial Update: D.T. PACE Versus High Dose Melphalan and Autologous Transplant in Patients With Previously Treated Multiple Myeloma [Phase 3]

View source ↗

Summary

Phase 3 trial update comparing the D.T. PACE chemotherapy regimen against high-dose melphalan with autologous transplant in patients with previously treated mul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• D.T. PACE regimen
• Melphalan (Melphalan)

Snippet

Sponsor: University of Arkansas | Conditions: Multiple Myeloma | Phase 3 | Status: COMPLETED